DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment

Information source: Mundipharma (China) Pharmaceutical Co. Ltd
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Other Acute Postoperative Pain

Intervention: Oxycodone (Drug); Morphine (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Mundipharma (China) Pharmaceutical Co. Ltd

Official(s) and/or principal investigator(s):
Mundipharma China Ltd., Study Chair, Affiliation: Mundipharma China Ltd.
Mundipharma China Ltd., Principal Investigator, Affiliation: Investigational Site Beijing, China

Summary

To determine the efficacy and safety of oxycodone i. v. patient-controlled analgesia (PCA) in the pain relieving treatment during 48h postoperative period, by comparing with morphine i. v. PCA.

Clinical Details

Official title: A Prospective, Randomized, Blind, Multicentre, Parallel Group Study to Investigate the Efficacy and Safety of Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Primary outcome:

Measuring VAS

Measuring VAS

Measuring VAS

Secondary outcome:

Dosage

The dosage of other rescue analgesic drugs used within 48h post-operation.

The invalid times and the total times of PCA application

Satisfaction degree for analgesia

AE occurrence and abnormal lab value

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria: 1. Patients of either sex aged 18 to 65 years old, with a standard body weight [standard

body weight = height (cm) - 100] ±15%.

2. ASA I and II. 3. Scheduled on elective open upper abdominal surgery under general anesthesia (liver, gall bladder, spleen, stomach, kidney, colon surgery), of which predicted operation duration is between 2-4h. 4. Hospitalized patients on non-emergency condition who have been given appropriate preoperative treatments. 5. Patients who are willing to participate in the study and have signed the written informed consent. 6. Negative pregnancy test result should be obtained for women of child-bearing age. Exclusion Criteria: 1. Long-term analgesics or psychotropic drugs (including opioids, NSAIDs, sedatives, antidepressants) taken for the chronic pain, or patients abusing alcohol. 2. Body weight is less than or over ±15% of the standard body weight. 3. Severe impairment of liver and renal function at preoperative stage (ALT, AST, BUN, Cr). 4. Medical history of recovering from abnormal surgery anesthesia. 5. Medical history of hypertension (Systolic blood pressure ≥180Hg, Diastolic blood pressure 110Hg). 6. Esophagus reflux disease. 7. Sedatives, anti-emetics, and anti-pruritic drugs were taken 24 hours before operation. 8. Have known hypersensitivity to opioids. 9. Monoamine oxidase inhibitors and antidepressant drugs were taken within 15 days. 10. Patients with shock. 11. Patients with COPD. 12. Patients can not understand the VAS or unable to use PCA. 13. Pregnant or parturient women.

Locations and Contacts

Investigational site, Beijing, Beijing 100022, China
Additional Information

Starting date: March 2010
Last updated: August 10, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017